KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Restructuring Costs (2016 - 2026)

Merck has reported Restructuring Costs over the past 18 years, most recently at $195.0 million for Q1 2026.

  • Quarterly Restructuring Costs rose 182.61% to $195.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Mar 2026, up 296.48% year-over-year, with the annual reading at $889.0 million for FY2025, 187.7% up from the prior year.
  • Restructuring Costs was $195.0 million for Q1 2026 at Merck, down from $213.0 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $560.0 million in Q2 2025 and troughed at $47.0 million in Q3 2025.
  • The 5-year median for Restructuring Costs is $94.0 million (2022), against an average of $137.1 million.
  • Year-over-year, Restructuring Costs plummeted 82.15% in 2022 and then skyrocketed 600.0% in 2025.
  • A 5-year view of Restructuring Costs shows it stood at $49.0 million in 2022, then surged by 420.41% to $255.0 million in 2023, then crashed by 80.0% to $51.0 million in 2024, then skyrocketed by 317.65% to $213.0 million in 2025, then fell by 8.45% to $195.0 million in 2026.
  • Per Business Quant, the three most recent readings for MRK's Restructuring Costs are $195.0 million (Q1 2026), $213.0 million (Q4 2025), and $47.0 million (Q3 2025).